Celsius’ (CELH) Outperform Rating Reaffirmed at Wedbush

Wedbush reissued their outperform rating on shares of Celsius (NASDAQ:CELH) in a research report report published on Friday, Benzinga reports. They currently have a $100.00 price target on the stock.

Several other brokerages have also recently issued reports on CELH. Jefferies Financial Group lifted their price objective on Celsius from $98.00 to $105.00 and gave the company a buy rating in a research note on Monday, March 18th. Maxim Group boosted their price target on shares of Celsius from $100.00 to $110.00 and gave the stock a buy rating in a report on Monday, April 1st. Morgan Stanley restated an equal weight rating and issued a $75.00 price objective on shares of Celsius in a report on Wednesday, March 27th. Bank of America downgraded shares of Celsius from a buy rating to a neutral rating and set a $65.00 target price for the company. in a research note on Friday, January 19th. Finally, UBS Group raised their price target on Celsius from $73.00 to $99.00 and gave the company a buy rating in a research note on Friday, March 1st. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Celsius presently has an average rating of Moderate Buy and a consensus target price of $85.45.

Celsius Price Performance

Shares of NASDAQ CELH traded up $1.59 during midday trading on Friday, hitting $75.97. The company’s stock had a trading volume of 4,214,836 shares, compared to its average volume of 3,531,141. Celsius has a 1 year low of $32.99 and a 1 year high of $99.62. The business’s fifty day simple moving average is $80.79 and its two-hundred day simple moving average is $65.47. The firm has a market capitalization of $17.55 billion, a price-to-earnings ratio of 98.24, a price-to-earnings-growth ratio of 2.17 and a beta of 1.93.

Celsius (NASDAQ:CELH) last posted its quarterly earnings results on Thursday, February 29th. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.16 by $0.01. The business had revenue of $347.44 million during the quarter, compared to the consensus estimate of $326.77 million. Celsius had a net margin of 17.21% and a return on equity of 131.58%. The company’s quarterly revenue was up 95.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.01 earnings per share. Analysts anticipate that Celsius will post 1.09 EPS for the current fiscal year.

Insider Buying and Selling

In other news, major shareholder William H. Milmoe sold 428,568 shares of the firm’s stock in a transaction that occurred on Wednesday, May 1st. The shares were sold at an average price of $59.67, for a total transaction of $25,572,652.56. Following the transaction, the insider now directly owns 25,035,885 shares in the company, valued at $1,493,891,257.95. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, CFO Jarrod Langhans sold 4,079 shares of the firm’s stock in a transaction dated Friday, April 19th. The stock was sold at an average price of $69.42, for a total transaction of $283,164.18. Following the transaction, the chief financial officer now owns 83,670 shares of the company’s stock, valued at $5,808,371.40. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, major shareholder William H. Milmoe sold 428,568 shares of the business’s stock in a transaction dated Wednesday, May 1st. The shares were sold at an average price of $59.67, for a total value of $25,572,652.56. Following the completion of the transaction, the insider now owns 25,035,885 shares in the company, valued at approximately $1,493,891,257.95. The disclosure for this sale can be found here. Insiders have sold 1,186,215 shares of company stock worth $80,215,119 in the last quarter. 2.20% of the stock is owned by insiders.

Institutional Trading of Celsius

A number of hedge funds have recently added to or reduced their stakes in the stock. Commonwealth Equity Services LLC lifted its position in Celsius by 93.1% in the third quarter. Commonwealth Equity Services LLC now owns 106,706 shares of the company’s stock valued at $18,311,000 after purchasing an additional 51,451 shares during the period. Cambridge Investment Research Advisors Inc. increased its position in Celsius by 89.1% during the third quarter. Cambridge Investment Research Advisors Inc. now owns 16,386 shares of the company’s stock worth $2,812,000 after purchasing an additional 7,723 shares during the last quarter. Raymond James Financial Services Advisors Inc. lifted its position in Celsius by 8.0% during the third quarter. Raymond James Financial Services Advisors Inc. now owns 53,237 shares of the company’s stock valued at $9,135,000 after buying an additional 3,921 shares in the last quarter. Bank of New York Mellon Corp lifted its position in Celsius by 8.5% during the 3rd quarter. Bank of New York Mellon Corp now owns 428,602 shares of the company’s stock worth $73,548,000 after acquiring an additional 33,597 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Celsius by 48.4% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 8,100 shares of the company’s stock worth $1,390,000 after acquiring an additional 2,643 shares in the last quarter. 60.95% of the stock is owned by institutional investors and hedge funds.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.